e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis
De Soyza Anthony, Perry Audrey, Hall Amanda J., Sunny Syba S., Walton Kathy E., Mustafa Nazim, Turton Jane, Kenna Dervla T., Winstanley Craig
Source:
Eur Respir J 2014; 43: 900-903
Journal Issue:
March
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
De Soyza Anthony, Perry Audrey, Hall Amanda J., Sunny Syba S., Walton Kathy E., Mustafa Nazim, Turton Jane, Kenna Dervla T., Winstanley Craig. Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis. Eur Respir J 2014; 43: 900-903
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Cystic fibrosis and intestinal organoids
Related content which might interest you:
Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
Source: Eur Respir J , 49 (4) 1602108; DOI: 10.1183/13993003.02108-2016
Year: 2017
Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2003; 22: 503-506
Year: 2003
Epidemiology and natural history of
Pseudomonas aeruginosa
airway infections in non-cystic fibrosis bronchiectasis
Source: ERJ Open Res, 4 (2) 00162-2017; 10.1183/23120541.00162-2017
Year: 2018
Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre
Source: Eur Respir J 2005; 25: 474-481
Year: 2005
Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis
Source: Eur Respir J 2005; 26: 651-656
Year: 2005
Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 379s
Year: 2002
Genotypic studies of pseudomonas aeruginosa isolates from adult non-cystic fibrosis bronchiectasis patients
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Pseudomonas aeruginosa infections
Source: Respipedia Article
Year: 2018
Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre
Source: Eur Respir J 2006; 27: 937-943
Year: 2006
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008
Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis
Source: Eur Respir J 2004; 24 : 631-637
Year: 2004
Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis – clinical application
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients
Source: Eur Respir J 2006 Oct 01;28(4):740-747
Year: 2006
Cystic fibrosis infection with clonal strains of Pseudomonas aeruginosa: current knowledge and future management
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=105
Year: 2006
DNA fingerprinting of pseudomonas aeruginosa in cystic fibrosis patients: risk assessment of cross-infection in a CF centre
Source: Eur Respir J 2002; 20: Suppl. 38, 208s
Year: 2002
Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients
Source: Eur Respir J 2004; 23: 851-856
Year: 2004
Molecular genetic characteristics of Pseudomonas aeruginosa strains isolated from children with cystic fibrosis in Moscow.
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics
Source: Eur Respir J 2008; 32: 1583-1590
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept